UnitedHealth’s Q3 Earnings Beat, DOJ Probe Raises Questions, Investors Remain Confident
UnitedHealth Group’s Q3 earnings beat expectations amid DOJ scrutiny of Medicare billing and a price‑increase plan, yet share buy‑backs show investor confidence in its future growth.
2 minutes to read









